As more investigational drugs become available vs COVID-19, is it time for PH to buy? | ABS-CBN
ADVERTISEMENT
Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
As more investigational drugs become available vs COVID-19, is it time for PH to buy?
As more investigational drugs become available vs COVID-19, is it time for PH to buy?
ABS-CBN News
Published Oct 30, 2021 01:04 PM PHT
|
Updated Oct 30, 2021 01:12 PM PHT
Watch more on iWantTFC.com. Watch hundreds of Pinoy shows, movies, live sports and news.
Watch more on iWantTFC.com. Watch hundreds of Pinoy shows, movies, live sports and news.
MANILA— Government's adviser for COVID-19 response on Saturday said more studies are needed before the country could procure investigational drugs for treatment, noting that it is only available through compassionate permits.
MANILA— Government's adviser for COVID-19 response on Saturday said more studies are needed before the country could procure investigational drugs for treatment, noting that it is only available through compassionate permits.
In a public briefing, Dr. Ted Herbosa pointed out that these could only be used with the authorization of the Food and Drug Administration (FDA) and the hospitals involved.
In a public briefing, Dr. Ted Herbosa pointed out that these could only be used with the authorization of the Food and Drug Administration (FDA) and the hospitals involved.
He added that patients that used the treatment would be observed for research purposes.
He added that patients that used the treatment would be observed for research purposes.
"So inaayos ata nila para magkaroon ng better access similar to the EUL, EUA system na mabigyan 'yan ng mga new drugs lalo na kung maganda ang efficacy nila katulad ng sa vaccines," Herbosa said.
"So inaayos ata nila para magkaroon ng better access similar to the EUL, EUA system na mabigyan 'yan ng mga new drugs lalo na kung maganda ang efficacy nila katulad ng sa vaccines," Herbosa said.
ADVERTISEMENT
The DOH on Friday said that it would soon buy investigational drugs vs COVID-19.
The DOH on Friday said that it would soon buy investigational drugs vs COVID-19.
To date, the Food and Drug Administration has only authorized ronapreve as treatment against the respiratory disease.
To date, the Food and Drug Administration has only authorized ronapreve as treatment against the respiratory disease.
Philippine health authorities are also using molnupiravir, remdesivir, tocilizumab and baricitinib as COVID-19 investigational drugs.
Philippine health authorities are also using molnupiravir, remdesivir, tocilizumab and baricitinib as COVID-19 investigational drugs.
Read More:
COVID-19
coronavirus
compassionate special permit
ronapreve
molnupiravir
remdesivir
tocilizumab
baricitinib
Ted Herbosa
ADVERTISEMENT
ADVERTISEMENT
